期刊文献+

亚毒性剂量阿霉素提高抗人DR4、DR5抗体诱导的神经胶质瘤细胞凋亡的研究 被引量:2

Enhancement of glioma cell apoptosis induced by anti-human DR5/DR4 monoclonal antibodies by sub-toxic dose of doxorubicin in human
下载PDF
导出
摘要 目的探讨亚毒性剂量的阿霉素影响抗DR4、DR5单克隆抗体(mAb)FMU1.4和FMU1.5诱导3株神经胶质瘤细胞株U343(TRAIL敏感株)、U138(TRAIL部分敏感株)及U373(TRAIL耐受株)凋亡的作用及可能的机制。方法采用流式细胞术检测DR4、DR5的表达及神经胶质瘤细胞中DNA倍增。用MTT比色法检测mAbFMU1.4和FMU1.5对3株神经胶质瘤细胞增殖的抑制作用。用共聚焦显微镜观察3株细胞中Ca2+的浓度。以Westernblot检测细胞内色素C、FLIP[FLICE-inhibitoryprotein,为一组含有死亡效应结构域(DED)的胞浆蛋白]的表达。结果亚毒性剂量的阿霉素作用后,DR5、DR4在3株细胞中的表达提高;而mAbFMU1.4、FMU1.5诱导U138和U373细胞凋亡的作用增强,细胞内细胞色素C的表达提高,FLIP的表达降低,Ca2+浓度增加。结论亚毒性剂量的阿霉素与抗DR4、DR5mAb联合应用后,可提高mAb诱导靶细胞凋亡的效应,其作用机制与DR4、DR5、细胞色素C、FLIP的表达及Ca2+的含量有关。 AIM: To study the cytotoxic effects of doxorubicin on apoptosis in glioma cell lines U343, U138, U373 induced by anti-human DR4/DR5 monoclonal antibodies (FMUI. 4/FMU1.5) and the underlying mechanism. METHODS: Expression of DR4/DR5 was quantitated by flow cytometry. Cytotoxicity exerted by FMU1.4/FMU1.5 on three cell lines was measured by MTT colorimetry and the induced apoptosis was determined by agarose gel electrophoresis. The expression of cytochrome C, FLIP and Ca^2+ concentration were also measured. RESULTS: Following the treat- ment of doxorubicin DR4 and DR5 were highly expressed on the cell surface; The apoptosis of U138 and U373 induced by FMUI. 4 and FMU1.5 was stronger, expression of cytochrome C and Ca^2+ concentration were enhanced, whereas the expression of FLIP was downregulated. CONCLUSION: Subtoxic doxorubicin applied with antibodies caused higher cell death rate of glioma cells, which may be relevant to DR4/DRS, the release of cytochrome C and FLIP and Ca^2 + concentration.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2007年第2期120-123,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 教育部跨世纪优秀人才培养计划资助项目(2000年)
关键词 TNF相关凋亡诱导配体 死亡受体 凋亡 阿霉素 TRAIL death receptor apoptosis doxorubicin
  • 相关文献

参考文献7

  • 1庄国洪,孙红光,杜柏榕,朱迅.抗人DR5单克隆抗体诱导U343细胞凋亡研究[J].中国肿瘤生物治疗杂志,2004,11(2):96-99. 被引量:9
  • 2Kang J,Bu J,Hao Y,et al.Subtoxic concentration of doxorubin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP[J].Prostate Cancer Prostatic Dis,2005,8(3):274-279.
  • 3董兰凤,梅和珊,宋淑霞,吕占军.rhIL-2与阿霉素长循环热敏脂质体靶向治疗肿瘤的协同作用[J].细胞与分子免疫学杂志,2005,21(3):296-300. 被引量:2
  • 4Shiraishi T,Yoshida T,Nakata S,et al.Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells[J].Cancer Res,2005,65(14):6364-6370.
  • 5Horinaka M,Yoshida T,Shiraishi T,et al.Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells[J].Ongene,2005,138(1):71-77.
  • 6Guo Y,Chen C,Zheng Y,et al.A novel anti-human DR5 monoclonal antibody with tumoricidal activity induces caspase-dependent and caspase-independent cell death[J].J Biol Chem,2005,280 (51):41940-41952.
  • 7Mori T,Doi R,Toyoda E,et al.Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancer[J].Surgery,2005,138(1):71-77.

二级参考文献18

  • 1Zhang XD, AV Franco,T Nguyen, et al. Diferent localization and regulation of death and decoy receptors for TNF-related apoptosisinducing ligand (TRAIL) in human melanoma cell[ J]. lmmumol, 2000, 164(8): 3961-3970.
  • 2Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of new member of the TNF family that induces apoptosis [J]. Immunity, 1995, 3 (6): 673-682.
  • 3Pitti RM, Marsters SA, Ruppert S, et al. Induction of apoptosis by Apo-21igand, a new member of the tumor necrosis factor cytikine family[ J ]. Biol Chem, 1996, 271 (22): 12687-12690.
  • 4Ichikawa K, Liu W, Zhao L, et al. Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity[J]. Nat Med, 2001, 7(8): 954-960.
  • 5Griffith TS, Chin WA, Jackson GC, et al. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells[ J]. Immunol, 1998, 161(6): 2833-2840.
  • 6Nicoletti Ⅰ ,Migliorati G, Pagliacci MC. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry [J]. Immunol, 1991, 139(2): 271-279.
  • 7Osamu I, Kazuo M, Hironobu Y, et al. Targeting chemotherapy to solid tumors with long-circulation thermosensitive liposomes and local hyperthermia[J]. Jpn J Cancer Res, 2000, 91: 18 -26.
  • 8Needham D, Anyarambhatla G, Kong G, et al. A new temperaturesensitive liposome for use with mild hyperthermia: charcterization and testing in a human tumor xenograft model[J]. Cancer Res, 2000, 60(5): 1197 -1201.
  • 9Woodle MC, Lasic DD. Sterically stabilized liposomes[J]. Biochim Biophys Acta, 1992, 1113(2): 171-199.
  • 10Sakae U, Kazuo M, Osamu I, et al. Enhanced tumor targeting and improved antitumor activity of doxorubicin by long-circulating liposomes containing amphipathic poly? (ethylene glycol ) [J]. Int J Pharmaceutics, 1995, 126:1-48.

共引文献9

同被引文献10

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部